Dr. Alexander Dobranowski and Scott Kelly joined the board of Vector Science & Therapeutics. The appointments bring healthcare AI expertise and capital markets experience to the newly listed TSXV company. This move strengthens the firm's leadership as it scales its therapeutic pipeline. Practitioners should watch for how these specific hires accelerate their AI-driven drug discovery.